Inmode Ltd
NASDAQ:INMD

Watchlist Manager
Inmode Ltd Logo
Inmode Ltd
NASDAQ:INMD
Watchlist
Price: 19.02 USD 2.89% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Inmode Ltd?
Write Note

Inmode Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inmode Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Inmode Ltd
NASDAQ:INMD
Revenue
$423.7m
CAGR 3-Years
10%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Revenue
$9.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Revenue
$31.8m
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
39%
Sisram Medical Ltd
HKEX:1696
Revenue
$356.4m
CAGR 3-Years
18%
CAGR 5-Years
17%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Revenue
$50.3m
CAGR 3-Years
127%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Epitomee Medical Ltd
TASE:EPIT
Revenue
$10m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Inmode Ltd
Revenue Breakdown

Breakdown by Geography
Inmode Ltd

Total Revenue: 492m USD
100%
United States: 307.8m USD
62.6%
Other: 121.7m USD
24.7%
Europe: 62.5m USD
12.7%

Breakdown by Segments
Inmode Ltd

Total Revenue: 492m USD
100%
Capital Equipment: 412.1m USD
83.7%
Consumables And Service Revenues: 80m USD
16.3%

Inmode Ltd
Glance View

Market Cap
1.6B USD
Industry
Health Care

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. The company designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. The company owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.

INMD Intrinsic Value
23.16 USD
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Inmode Ltd's Revenue?
Revenue
423.7m USD

Based on the financial report for Sep 30, 2024, Inmode Ltd's Revenue amounts to 423.7m USD.

What is Inmode Ltd's Revenue growth rate?
Revenue CAGR 5Y
25%

Over the last year, the Revenue growth was -15%. The average annual Revenue growth rates for Inmode Ltd have been 10% over the past three years , 25% over the past five years .

Back to Top